MEENAKSHI GOPAL: Open Payments
NPI 1003861915 · WINCHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,095 in 44 payments from 12 companies in 2025. Trend: 2023 $1,010 · 2024 $732 · 2025 $1,095
Food & beverage: $1,095
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $401 |
| ABBVIE INC. | 12 | $250 |
| Medtronic, Inc. | 4 | $116 |
| PFIZER INC. | 4 | $84 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $57 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Exact Sciences Corporation | 1 | $28 |
| Kowa Pharmaceuticals America, Inc. | 2 | $28 |
| Lilly USA, LLC | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
Products named: Ozempic, VRAYLAR, MINIMED 780G, Wegovy, QULIPTA, PREVNAR 20, Kerendia, Rybelsus.
Industry payments across VA — which companies pay providers there.
